878 filings
8-K
OTLC
Oncotelic Therapeutics, Inc.
2 Feb 24
Entry into a Material Definitive Agreement
5:00pm
10-Q
2023 Q3
OTLC
Oncotelic Therapeutics, Inc.
Quarterly report
14 Nov 23
12:00am
8-K
OTLC
Oncotelic Therapeutics, Inc.
30 Oct 23
Entry into a Material Definitive Agreement
9:00am
8-K
OTLC
Oncotelic Therapeutics, Inc.
23 Aug 23
Regulation FD Disclosure
10:30am
10-Q
2023 Q2
OTLC
Oncotelic Therapeutics, Inc.
Quarterly report
18 Aug 23
5:00pm
NT 10-Q
xl0ba
14 Aug 23
Notice of late quarterly filing
5:35pm
D
u0wl2uve 29
13 Jul 23
$5.00 mm in debt / options / securities to be acquired, 15 investors
12:00am
8-K
ufsufgwav7n0xf
13 Jul 23
Entry into a Material Definitive Agreement
12:00am
4
4w8ach5xe6u3hh
30 Jun 23
Oncotelic Therapeutics / Vuong Trieu ownership change
9:25am
4
aevtuf tk
20 Jun 23
Oncotelic Therapeutics / Vuong Trieu ownership change
12:00pm
4
nea4mpyin18e58rid
16 Jun 23
Oncotelic Therapeutics / Vuong Trieu ownership change
12:00pm
4
1b486
31 May 23
Oncotelic Therapeutics / Vuong Trieu ownership change
9:39am
8-K
fyefcdmrvgfysih20he
19 May 23
Amendments to Articles of Incorporation or Bylaws
4:45pm
NT 10-Q
lfn18ez
15 May 23
Notice of late quarterly filing
5:15pm
424B3
5iho3
2 May 23
Prospectus supplement
5:15pm
4
xdtj75m2 29
2 May 23
Oncotelic Therapeutics / Vuong Trieu ownership change
5:00pm
EFFECT
nb46gjl3wkl6xyexbph
26 Apr 23
Notice of effectiveness
12:15am
POS AM
8tvre8bbk
19 Apr 23
Prospectus update (post-effective amendment)
9:00pm